Our study revealed that, in bladder cancer, progression from non‐muscle‐invasive to muscle‐invasive and metastatic is associated with decreased Nectin‐4 expression and increased ABC transporter expression. Here, NECTIN4 is linked to urinary bladder carcinoma.